Shoubhik Mondal

Shoubhik Mondal

AstraZeneca, Sweden - Södertälje / Sweden
Medical and Health Sciences / Biostatistics
AD Scientific Index ID: 4403823
-
person_outline Shoubhik Mondal's MOST POPULAR ARTICLES
1-) Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced …GN Hortobagyi, SM Stemmer, HA Burris, YS Yap, GS Sonke, ...Annals of Oncology 29 (7), 1541-1547, 20184902018
2-) Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2− advanced breast cancer in the randomized MONALEESA-2 trialJ O’shaughnessy, K Petrakova, GS Sonke, P Conte, CL Arteaga, ...Breast cancer research and treatment 168 (1), 127-134, 2018892018
3-) Review of calculation of conditional power, predictive power and probability of success in clinical trials with continuous, binary and time-to-event endpointsMG Kundu, S Samanta, S MondalHealth Services and Outcomes Research Methodology 24 (1), 14-45, 20249*2024
4-) Model assisted Cox regressionS Mondal, S SubramanianJournal of Multivariate Analysis 123, 281-303, 201492014
5-) Model checks for two-sample location-scaleA Javidialsaadi, S Mondal, S SubramanianJournal of Nonparametric Statistics 36 (3), 749-779, 202472024